AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32657029 — intervention group
Group type: COMPARATOR
Intervention: FP regimen (5-fluorouracil plus cisplatin)
Number of subjects: 135
Study 36451379 — intervention group
Group type: EXPERIMENTAL
Intervention: Telenursing counseling (3 sessions for 6 weeks)
Number of subjects: 108
Study 36451379 — intervention group
Group type: COMPARATOR
Intervention: Control group (no active intervention)
Number of subjects: 108
Study 34811433 — intervention group
Group type: EXPERIMENTAL
Intervention: Bimanual (BM) digit training
Number of subjects: 48
Study 34811433 — intervention group
Group type: COMPARATOR
Intervention: Right-hand (RH) training
Number of subjects: 48
Study 35221680 — intervention group
Group type: EXPERIMENTAL
Intervention: iCST app
Number of subjects: 61
Study 35221680 — intervention group
Group type: COMPARATOR
Intervention: Treatment-as-usual (TAU)
Number of subjects: 61
Study 32494128 — intervention group
Group type: EXPERIMENTAL
Intervention: Nordic walking (NW) training for 12 weeks
Number of subjects: 76
Study 32494128 — intervention group
Group type: COMPARATOR
Intervention: Control group (no exercise)
Number of subjects: 76
Study 35747928 — intervention group
Group type: EXPERIMENTAL
Intervention: Viral testing (overall and stratified by testing method)
Number of subjects: 46038
Study 35747928 — intervention group
Group type: EXPERIMENTAL
Intervention: Molecular testing
Number of subjects: 46038
Study 35747928 — intervention group
Group type: EXPERIMENTAL
Intervention: Antigen testing
Number of subjects: 46038
Study 35747928 — intervention group
Group type: COMPARATOR
Intervention: Hospital-specific adjusted proportions of testing
Number of subjects: 46038
Study 35747928 — intervention group
Group type: COMPARATOR
Intervention: Viral testing practices
Number of subjects: 46038
Study 34483020 — intervention group
Group type: EXPERIMENTAL
Intervention: SYN023 + Imovax
Number of subjects: 164
Study 34483020 — intervention group
Group type: EXPERIMENTAL
Intervention: SYN023 + RabAvert
Number of subjects: 164
Study 34483020 — intervention group
Group type: COMPARATOR
Intervention: HyperRab + Imovax
Number of subjects: 164
Study 34483020 — intervention group
Group type: COMPARATOR
Intervention: HyperRab + RabAvert
Number of subjects: 164
Study 34483020 — intervention group
Group type: EXPERIMENTAL
Intervention: SYN023
Number of subjects: 164
Study 34483020 — intervention group
Group type: COMPARATOR
Intervention: HyperRab
Number of subjects: 164
Study 34483020 — intervention group
Group type: EXPERIMENTAL
Intervention: SYN023 and HyperRab
Number of subjects: 164
Study 35171266 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 1 - Mesenteric sparing ileocolic resection (ICR)
Number of subjects: 138
Study 35171266 — intervention group
Group type: COMPARATOR
Intervention: Group 2 - Extensive mesenteric ICR
Number of subjects: 138
Study 34709859 — intervention group
Group type: EXPERIMENTAL
Intervention: Culturally tailored fruit drink countermarketing messages (fruit drink‒only group)
Number of subjects: 1628
Study 34709859 — intervention group
Group type: EXPERIMENTAL
Intervention: Countermarketing and water promotion messages combined (combination group)
Number of subjects: 1628
Study 34709859 — intervention group
Group type: COMPARATOR
Intervention: Car-seat safety messages (control)
Number of subjects: 1628
Study 34954069 — intervention group
Group type: EXPERIMENTAL
Intervention: Scopolamine butylbromide given prophylactically for death rattle
Number of subjects: 1097
Study 34954069 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1097
Study 33737346 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive assessment of IRH severity including laboratory biomarkers and clinical features
Number of subjects: 0
Study 33737346 — intervention group
Group type: COMPARATOR
Intervention: Current treatment based on CTCAE grading
Number of subjects: 0
Study 32506858 — intervention group
Group type: EXPERIMENTAL
Intervention: Honey mouthwash 12.5%
Number of subjects: 60
Study 32506858 — intervention group
Group type: COMPARATOR
Intervention: Chlorhexidine solution 0.2%
Number of subjects: 60
Study 33274816 — intervention group
Group type: EXPERIMENTAL
Intervention: Physician's recommendation (surgery)
Number of subjects: 201
Study 33274816 — intervention group
Group type: EXPERIMENTAL
Intervention: Physician's recommendation (physiotherapy)
Number of subjects: 201
Study 33274816 — intervention group
Group type: EXPERIMENTAL
Intervention: Congruent physician's recommendation
Number of subjects: 201
Study 33274816 — intervention group
Group type: EXPERIMENTAL
Intervention: Contrary physician's recommendation
Number of subjects: 201
Study 32964800 — intervention group
Group type: EXPERIMENTAL
Intervention: NT-proBNP alone
Number of subjects: 5509
Study 32964800 — intervention group
Group type: EXPERIMENTAL
Intervention: NT-proBNP added to the base model
Number of subjects: 5509
Study 32964800 — intervention group
Group type: COMPARATOR
Intervention: Base model
Number of subjects: 5509
Study 35688585 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive training plus anodal tDCS over left dorsolateral prefrontal cortex for 2 weeks, 20 min sessions at 1.5 mA
Number of subjects: 30
Study 35688585 — intervention group
Group type: COMPARATOR
Intervention: Cognitive training plus sham stimulation
Number of subjects: 30
Study 33529708 — intervention group
Group type: EXPERIMENTAL
Intervention: Imprecise group (visual feedback offset 30 to 50 mm from true location)
Number of subjects: 40
Study 33529708 — intervention group
Group type: COMPARATOR
Intervention: Precise group (vision not disrupted)
Number of subjects: 40
Study 33529708 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 40
Study 32512184 — intervention group
Group type: EXPERIMENTAL
Intervention: Active aiTBS
Number of subjects: 46
Study 32512184 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 46
Study 35306716 — intervention group
Group type: EXPERIMENTAL
Intervention: I-CoreDIST
Number of subjects: 19
Study 35306716 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 19
Study 33109949 — intervention group
Group type: EXPERIMENTAL
Intervention: Epinephrine
Number of subjects: 8000
Study 35088231 — intervention group
Group type: EXPERIMENTAL
Intervention: Nivolumab plus standard chemotherapy
Number of subjects: 0
Study 35088231 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy alone
Number of subjects: 0
Study 34840512 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief Advice and Counselling
Number of subjects: 351
Study 34840512 — intervention group
Group type: EXPERIMENTAL
Intervention: Five-minute Brief Advice
Number of subjects: 351
Study 34840512 — intervention group
Group type: COMPARATOR
Intervention: Patient Information Leaflet
Number of subjects: 351
Study 35076138 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraarticular injections with 20 mg gold microparticles
Number of subjects: 30
Study 33369870 — intervention group
Group type: EXPERIMENTAL
Intervention: Intratympanic (IT) dexamethasone administered once every other day for 24 days
Number of subjects: 0
Study 33369870 — intervention group
Group type: COMPARATOR
Intervention: Intravenous (IV) dexamethasone for 12 days followed by IT dexamethasone once every other day for 12 days
Number of subjects: 0
Study 35855628 — intervention group
Group type: EXPERIMENTAL
Intervention: EMG‐driven robotic rehabilitation (Hand of Hope®) with neurophysiological rehabilitation, 15 sessions over 3 weeks
Number of subjects: 24
Study 35855628 — intervention group
Group type: COMPARATOR
Intervention: Neurophysiological rehabilitation (control group)
Number of subjects: 24
Study 33309460 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin (24 IU, once daily for four weeks)
Number of subjects: 34
Study 33309460 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study 33309460 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin
Number of subjects: 34
Study 33121204 — intervention group
Group type: EXPERIMENTAL
Intervention: interACTION system (n = 13)
Number of subjects: 25
Study 33121204 — intervention group
Group type: COMPARATOR
Intervention: Standard post-operative outpatient rehabilitation program (n = 12)
Number of subjects: 25
Study 36457059 — intervention group
Group type: EXPERIMENTAL
Intervention: ceftolozane/tazobactam (3 g [2 g ceftolozane/1 g tazobactam] every 8 h)
Number of subjects: 93
Study 36457059 — intervention group
Group type: COMPARATOR
Intervention: meropenem (1 g every 8 h)
Number of subjects: 93
Study 33463692 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically determined vitamin D levels
Number of subjects: 600000
Study 33301887 — intervention group
Group type: EXPERIMENTAL
Intervention: NSE levels at 24 hours
Number of subjects: 101
Study 33301887 — intervention group
Group type: EXPERIMENTAL
Intervention: NSE levels at 48 hours
Number of subjects: 101
Study 33301887 — intervention group
Group type: EXPERIMENTAL
Intervention: NSE levels at 72 hours
Number of subjects: 101
Study 33301887 — intervention group
Group type: EXPERIMENTAL
Intervention: NSE at 48 hours
Number of subjects: 101
Study 33301887 — intervention group
Group type: EXPERIMENTAL
Intervention: NSE at 72 hours
Number of subjects: 101
Study 33301887 — intervention group
Group type: COMPARATOR
Intervention: Temperature management (33°C vs 37°C)
Number of subjects: 101
Study 32036192 — intervention group
Group type: EXPERIMENTAL
Intervention: Supplemental perinatal contraceptive counselling (intervention group)
Number of subjects: 975
Study 32036192 — intervention group
Group type: COMPARATOR
Intervention: Standard Spanish postpartum contraceptive counselling (control group)
Number of subjects: 975
Study 32036192 — intervention group
Group type: COMPARATOR
Intervention: Standard clinical practice (control group)
Number of subjects: 975
Study 35963558 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined treatment (d-methylphenidate and guanfacine)
Number of subjects: 172
Study 35963558 — intervention group
Group type: EXPERIMENTAL
Intervention: d-methylphenidate
Number of subjects: 172
Study 35963558 — intervention group
Group type: EXPERIMENTAL
Intervention: guanfacine
Number of subjects: 172
Study 32965476 — intervention group
Group type: EXPERIMENTAL
Intervention: Clopidogrel plus aspirin (dual antiplatelet therapy) for 3 months
Number of subjects: 171
Study 32965476 — intervention group
Group type: COMPARATOR
Intervention: Aspirin plus placebo (single antiplatelet therapy) for 3 months
Number of subjects: 171
Study 32965476 — intervention group
Group type: EXPERIMENTAL
Intervention: Clopidogrel group at 6 months
Number of subjects: 171
Study 32965476 — intervention group
Group type: COMPARATOR
Intervention: Placebo group at 6 months
Number of subjects: 171
Study 32965476 — intervention group
Group type: EXPERIMENTAL
Intervention: Clopidogrel group at 12 months
Number of subjects: 171
Study 32965476 — intervention group
Group type: COMPARATOR
Intervention: Placebo group at 12 months
Number of subjects: 171
Study 32965476 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall severity of migraine attacks
Number of subjects: 171
Study 32965476 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall incidence of migraine attacks after 3 months
Number of subjects: 171
Study 32484877 — intervention group
Group type: EXPERIMENTAL
Intervention: Whey protein
Number of subjects: 48
Study 32484877 — intervention group
Group type: EXPERIMENTAL
Intervention: Vegetable protein
Number of subjects: 48
Study 32484877 — intervention group
Group type: EXPERIMENTAL
Intervention: Animal protein
Number of subjects: 48
Study 32484877 — intervention group
Group type: EXPERIMENTAL
Intervention: All protein types (whey, vegetable, animal)
Number of subjects: 48
Study 32484877 — intervention group
Group type: EXPERIMENTAL
Intervention: VLCKDs (all types)
Number of subjects: 48
Study 33801537 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile mental health apps based on cognitive behavior theory, stress theory, and ecological instant intervention theory (including breathing training, meditation, and music therapy)
Number of subjects: 1205
Study 33017804 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-km cycling time trial at 08:30
Number of subjects: 19
Study 33017804 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-km cycling time trial at 11:30
Number of subjects: 19
Study 33017804 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-km cycling time trial at 14:30
Number of subjects: 19
Study 33017804 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-km cycling time trial at 17:30
Number of subjects: 19
Study 33017804 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-km cycling time trial at 20:30
Number of subjects: 19
Study 33017804 — intervention group
Group type: EXPERIMENTAL
Intervention: Preexercise tympanic temperature at 14:30 and 17:30
Number of subjects: 19
Study 34779103 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitagliptin 100 mg daily
Number of subjects: 220
Study 34779103 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 220
Study 32823324 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed-suction drains (MD)
Number of subjects: 53
Study 32823324 — intervention group
Group type: COMPARATOR
Intervention: No closed-suction drains (OD)
Number of subjects: 53
Study 32456955 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D model‐assisted surgery
Number of subjects: 37
Study 32456955 — intervention group
Group type: COMPARATOR
Intervention: Conventional surgery
Number of subjects: 37
Study 32649395 — intervention group
Group type: EXPERIMENTAL
Intervention: Active group music therapy program (3 months, twice per week, 60 minutes per session)
Number of subjects: 146
Study 32649395 — intervention group
Group type: COMPARATOR
Intervention: Daily activities (comparison group)
Number of subjects: 146
Study 36775504 — intervention group
Group type: EXPERIMENTAL
Intervention: Superficial dry needling (SDN)
Number of subjects: 47
Study 36775504 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep dry needling (DDN)
Number of subjects: 47
Study 34124927 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard clinic-based cognitive behavioral therapy (S-CBT)
Number of subjects: 436
Study 34124927 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimal therapist contact cognitive behavioral therapy (MC-CBT)
Number of subjects: 436
Study 34124927 — intervention group
Group type: COMPARATOR
Intervention: Education/Support (EDU)
Number of subjects: 436
Study 32949063 — intervention group
Group type: EXPERIMENTAL
Intervention: HFrecEF (cases)
Number of subjects: 136
Study 32949063 — intervention group
Group type: COMPARATOR
Intervention: HFrEF non-recovered (controls)
Number of subjects: 136
Study 36495477 — intervention group
Group type: EXPERIMENTAL
Intervention: Mandated case review of high-risk patients prescribed opioids
Number of subjects: 28251
Study 36495477 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients who received an opioid prescription prior to but not after OUD diagnosis
Number of subjects: 28251
Study 36495477 — intervention group
Group type: COMPARATOR
Intervention: Control patients (not specified in detail)
Number of subjects: 28251
Study 34008076 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-exome sequencing (WES)
Number of subjects: 1
Study 35780607 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep learning-based synthetic CT (sCT)
Number of subjects: 25
Study 35780607 — intervention group
Group type: COMPARATOR
Intervention: Conventional CT
Number of subjects: 25
Study 33525270 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.3g/Kg of a glucose preparation
Number of subjects: 21
Study 33525270 — intervention group
Group type: EXPERIMENTAL
Intervention: Sugar fondant candies
Number of subjects: 21
Study 33525270 — intervention group
Group type: EXPERIMENTAL
Intervention: Fruit juice
Number of subjects: 21
Study 34688473 — intervention group
Group type: EXPERIMENTAL
Intervention: High-flow nasal cannula (HFNC)
Number of subjects: 118
Study 34688473 — intervention group
Group type: COMPARATOR
Intervention: Tracheal intubation
Number of subjects: 118
Study 32615837 — intervention group
Group type: EXPERIMENTAL
Intervention: ‘ward’ vaginal tablet containing 200 mg of dried extract applied vaginally for 7 consecutive nights
Number of subjects: 92
Study 32615837 — intervention group
Group type: COMPARATOR
Intervention: Placebo (corn starch and lactose) applied vaginally for 7 consecutive nights
Number of subjects: 92
Study 34955699 — intervention group
Group type: EXPERIMENTAL
Intervention: Female investigator
Number of subjects: 40
Study 34955699 — intervention group
Group type: COMPARATOR
Intervention: Male investigator
Number of subjects: 40
Study 34955699 — intervention group
Group type: EXPERIMENTAL
Intervention: First series of stimulation
Number of subjects: 40
Study 34304030 — intervention group
Group type: EXPERIMENTAL
Intervention: COVID-19 safety protocols for conducting the ESSENCE trial
Number of subjects: 0
Study 34304030 — intervention group
Group type: EXPERIMENTAL
Intervention: Guidelines for supervisors, travellers, training/recruitment venue safety procedures, individual safety procedures
Number of subjects: 0
Study 33422263 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuation of renin–angiotensin system inhibitors
Number of subjects: 152
Study 33422263 — intervention group
Group type: COMPARATOR
Intervention: Discontinuation of renin–angiotensin system inhibitors
Number of subjects: 152
Study 34628697 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive care and education with serial consultations with HF specialist and dietician during the first 2-3 weeks
Number of subjects: 482
Study 34628697 — intervention group
Group type: COMPARATOR
Intervention: Standard post-discharge care according to guidelines
Number of subjects: 482
Study 33639897 — intervention group
Group type: EXPERIMENTAL
Intervention: Sildenafil 50 mg
Number of subjects: 20
Study 33639897 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 33031764 — intervention group
Group type: EXPERIMENTAL
Intervention: Lopinavir-ritonavir (400 mg and 100 mg, respectively) by mouth for 10 days or until discharge
Number of subjects: 5040
Study 33031764 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 5040
Study 33031764 — intervention group
Group type: EXPERIMENTAL
Intervention: Lopinavir-ritonavir
Number of subjects: 5040
Study 33031764 — intervention group
Group type: EXPERIMENTAL
Intervention: Lopinavir-ritonavir (among patients not on invasive mechanical ventilation at baseline)
Number of subjects: 5040
Study 33031764 — intervention group
Group type: COMPARATOR
Intervention: Usual care (among patients not on invasive mechanical ventilation at baseline)
Number of subjects: 5040
Study 35057571 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactiplantibacillus plantarum CJLP243
Number of subjects: 24
Study 35057571 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 33082286 — intervention group
Group type: EXPERIMENTAL
Intervention: 60 mL 0.375% ropivacaine
Number of subjects: 70
Study 33082286 — intervention group
Group type: COMPARATOR
Intervention: 60 mL isotonic saline (placebo)
Number of subjects: 70
Study 613168068 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotinamide (300 mg)
Number of subjects: 30
Study 613168068 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotinic acid (300 mg)
Number of subjects: 30
Study 613168068 — intervention group
Group type: COMPARATOR
Intervention: Purified water (Control)
Number of subjects: 30
Study 34953155 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosuvastatin 20 mg/day for 28 days
Number of subjects: 245
Study 34953155 — intervention group
Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 245
Study 34311749 — intervention group
Group type: EXPERIMENTAL
Intervention: Vegetables only for 28 days
Number of subjects: 120
Study 34311749 — intervention group
Group type: COMPARATOR
Intervention: Fruit and vegetables for 28 days
Number of subjects: 120
Study 34311749 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 120
Study 32198149 — intervention group
Group type: EXPERIMENTAL
Intervention: Nivolumab
Number of subjects: 188
Study 32198149 — intervention group
Group type: EXPERIMENTAL
Intervention: Docetaxel
Number of subjects: 188
Study 32198149 — intervention group
Group type: EXPERIMENTAL
Intervention: Gefitinib
Number of subjects: 188
Study 32198149 — intervention group
Group type: EXPERIMENTAL
Intervention: Serial radiographic measurements
Number of subjects: 188
Study 32407532 — intervention group
Group type: EXPERIMENTAL
Intervention: Pembrolizumab 200 mg
Number of subjects: 469
Study 32407532 — intervention group
Group type: COMPARATOR
Intervention: Standard of Care (SOC)
Number of subjects: 469
Study 33027765 — intervention group
Group type: EXPERIMENTAL
Intervention: Dry Needling (DN)
Number of subjects: 40
Study 33027765 — intervention group
Group type: COMPARATOR
Intervention: Static Stretching (SS)
Number of subjects: 40
Study 35447502 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous calcium chloride (1 gram)
Number of subjects: 40
Study 35447502 — intervention group
Group type: COMPARATOR
Intervention: Saline placebo control
Number of subjects: 40
Study 33834863 — intervention group
Group type: EXPERIMENTAL
Intervention: Fufang E’jiao Syrup (FFEJS), 20 ml, 3 times a day for 6 weeks
Number of subjects: 0
Study 33834863 — intervention group
Group type: COMPARATOR
Intervention: Placebo, 20 ml, 3 times a day for 6 weeks
Number of subjects: 0
Study 33834863 — intervention group
Group type: EXPERIMENTAL
Intervention: Fufang E’jiao Syrup (FFEJS)
Number of subjects: 0
Study 33834863 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 32681734 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-intensity endurance training program (n = 15)
Number of subjects: 33
Study 32681734 — intervention group
Group type: COMPARATOR
Intervention: Non-training group (n = 18)
Number of subjects: 33
Study 35750564 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-irrigation with tap water using a syringe three times a day, starting seven days after tooth extraction
Number of subjects: 155
Study 35750564 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-irrigation with tap water
Number of subjects: 155
Study 34179759 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-aminopyridine (4-AP)
Number of subjects: 19
Study 34179759 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study 34999739 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole grain wheat products (semolina)
Number of subjects: 16
Study 34999739 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole grain wheat products (cracked wheat)
Number of subjects: 16
Study 34999739 — intervention group
Group type: COMPARATOR
Intervention: Whole wheat flour porridge
Number of subjects: 16
Study 33823195 — intervention group
Group type: EXPERIMENTAL
Intervention: Cigarette smoke
Number of subjects: 0
Study 33823195 — intervention group
Group type: COMPARATOR
Intervention: Biomass smoke
Number of subjects: 0